Stay updated on Psilocybin for MDD: Novel Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.

Latest updates to the Psilocybin for MDD: Novel Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a recruitment status notice ('No longer looking for participants') and new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) with an updated revision tag (v3.6.0). Replaced the 'Intervention / Treatment' label with 'Intervention/Treatment', and removed the prior revision entry 'v3.5.5'.SummaryDifference0.4%

- Check21 days agoChange DetectedSite footer Revision updated from v3.5.4 to v3.5.5, indicating a new version of the site software.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page now displays Revision: v3.5.4, indicating a small update to the site’s build; no study information or functionality within the page is altered.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a minor page version update. This administrative change does not alter the study details or the information presented on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedResults were posted for this trial, including updated study record/result timing and linked documents. Key outcome measures and endpoints (MADRS change at Day 43 and Day 8, Sheehan Disability Scale change at Day 43, and sustained response/remission thresholds) were added/updated to reflect the reported analyses.SummaryDifference2%

- Check71 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. This appears to be a minor version bump with no changes to study content, layout, or other user-facing information.SummaryDifference0.0%

Stay in the know with updates to Psilocybin for MDD: Novel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.